GlaxoSmithKline Consumer Healthcare Limited Sustainability Profile
GlaxoSmithKline Consumer Healthcare Limited, commonly referred to as GSK Consumer Healthcare, is a leading player in the global consumer health industry, headquartered in India. Established as a key division of GlaxoSmithKline, the company focuses on delivering innovative health solutions across major operational regions, including Asia, Europe, and North America. Founded in the early 2000s, GSK Consumer Healthcare has achieved significant milestones, including the development of a diverse portfolio of core products such as oral health, pain relief, and wellness supplements. Their unique approach combines scientific research with consumer insights, ensuring high-quality offerings that meet everyday health needs. With a strong market position, GSK Consumer Healthcare is recognised for its commitment to improving health and well-being, making it a trusted name among consumers worldwide.
DitchCarbon Score
How does GlaxoSmithKline Consumer Healthcare Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Beverage Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GlaxoSmithKline Consumer Healthcare Limited's score of 27 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
GlaxoSmithKline Consumer Healthcare Limited, headquartered in India, currently does not have specific carbon emissions data available for the most recent year. The company has not disclosed any absolute emissions figures, including Scope 1, 2, or 3 emissions, nor has it set any documented reduction targets or climate pledges. However, emissions data may be inherited from its corporate family, specifically from Hindustan Unilever Limited, which is a merged entity at the first cascade level. This relationship suggests that GSK Consumer Healthcare may align its climate commitments with those of Hindustan Unilever, although specific figures or targets have not been provided. As of now, GSK Consumer Healthcare's climate commitments remain vague, with no clear initiatives or targets outlined in the available data. The company is expected to follow industry standards and best practices in addressing climate change, but further details on specific actions or commitments are not currently accessible.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 758,232,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 893,825,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 62,017,585,000 | 00,000,000,000 | 00,000,000,000 | - | 0,000,000,000 | - |
How Carbon Intensive is GlaxoSmithKline Consumer Healthcare Limited's Industry?
How Carbon Intensive is GlaxoSmithKline Consumer Healthcare Limited's Location?
GlaxoSmithKline Consumer Healthcare Limited's Scope 3 Categories Breakdown
GlaxoSmithKline Consumer Healthcare Limited's Scope 3 emissions, which decreased by 84% last year and decreased by approximately 85% since 2018, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Use of Sold Products" representing nearly all of their reported Scope 3 footprint.
Top Scope 3 Categories
GlaxoSmithKline Consumer Healthcare Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
GlaxoSmithKline Consumer Healthcare Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
